Biogen Picks Ex-Sanofi Exec as Leader
- Posted by ISPE Boston
- On November 17, 2022
Biogen has appointed Christopher Viehbacher as President and Chief Executive Officer and a member of the Board of Directors, effective November 14. Viehbacher succeeds Michel Vounatsos, who has led the company since 2017. Viehbacher has extensive international experience in both large pharmaceutical companies and entrepreneurial biotech companies. After 20 years with GlaxoSmithKline, he served as […]
Read More